Page last updated: 2024-10-24

positive regulation of lysosomal protein catabolic process

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of lysosomal protein catabolic process. [GO_REF:0000058, GOC:bf, GOC:PARL, GOC:TermGenie]

Positive regulation of lysosomal protein catabolic process involves a complex interplay of molecular mechanisms that precisely control the breakdown of proteins within lysosomes. Lysosomes are membrane-bound organelles that act as the cellular recycling centers, degrading various macromolecules including proteins. The process of positive regulation ensures that lysosomal protein catabolism occurs efficiently and at the appropriate time, contributing to cellular homeostasis and maintaining cellular function.

**Key Steps and Players:**

1. **Signal Recognition:** The process begins with the recognition of specific signals on proteins destined for lysosomal degradation. These signals can be in the form of amino acid sequences or post-translational modifications.
2. **Sorting and Targeting:** Recognized proteins are sorted and targeted to lysosomes via various pathways, including:
* **Chaperone-mediated autophagy (CMA):** Specific chaperones bind to target proteins and deliver them to lysosomes for degradation.
* **Microautophagy:** Small portions of cytoplasm, including proteins, are directly engulfed by lysosomes through invaginations of the lysosomal membrane.
* **Macroautophagy:** A more prominent pathway where cellular components, including proteins, are encapsulated within double-membrane vesicles called autophagosomes. These autophagosomes then fuse with lysosomes, delivering their cargo for degradation.
3. **Lysosomal Degradation:** Lysosomes contain a diverse array of hydrolytic enzymes, including proteases, lipases, and nucleases. These enzymes break down the proteins into smaller peptides and amino acids.
4. **Regulation and Feedback:** The entire process is tightly regulated by various factors, including:
* **Nutrient availability:** Cells increase lysosomal protein degradation during starvation or nutrient deprivation to provide essential building blocks.
* **Stress response:** Cellular stress, such as oxidative stress or infection, often triggers lysosomal protein degradation as a protective mechanism.
* **Cellular signaling pathways:** Multiple signaling pathways, such as the mTOR pathway and the MAPK pathway, influence lysosomal activity.

**Examples of Positive Regulators:**

* **mTOR:** A key regulator of cellular growth and metabolism, mTOR activation can suppress lysosomal degradation. Conversely, inhibition of mTOR signaling can stimulate lysosomal activity.
* **Autophagy-related proteins (ATGs):** ATGs, such as ATG5 and ATG7, are essential for the formation of autophagosomes, thereby promoting lysosomal protein degradation.
* **Lysosomal chaperones:** Chaperones like LAMP-2A facilitate the delivery of proteins to lysosomes for degradation through CMA.
* **Signaling molecules:** Hormones like insulin and growth factors can regulate lysosomal protein degradation through their downstream signaling pathways.

**Consequences of Dysregulation:**

Defects in the positive regulation of lysosomal protein catabolism can lead to various diseases. For example, mutations in genes involved in autophagy can result in accumulation of misfolded proteins, contributing to neurodegenerative disorders like Parkinson's disease and Alzheimer's disease. Additionally, impaired lysosomal function can lead to cellular dysfunction and disease development.

**In conclusion, positive regulation of lysosomal protein catabolic process is a crucial cellular process that involves a complex interplay of molecular mechanisms. This process ensures the efficient breakdown of proteins within lysosomes, contributing to cellular homeostasis and preventing the accumulation of harmful or misfolded proteins. Dysregulation of this process can have significant consequences for cell function and overall health.**'
"

Proteins (1)

ProteinDefinitionTaxonomy
Low-density lipoprotein receptorA low-density lipoprotein receptor that is encoded in the genome of human. [PRO:DNx, UniProtKB:P01130]Homo sapiens (human)

Compounds (1)

CompoundDefinitionClassesRoles
s 1033(trifluoromethyl)benzenes;
imidazoles;
pyridines;
pyrimidines;
secondary amino compound;
secondary carboxamide
anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor